Antidepressant Drugs Flashcards

1
Q

Antidepressant drugs are effective for treating moderate to severe depression associated with __________ and ____________ changes such as loss of appetite and sleep disturbance

A

psychomotor

physiological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antidepressant drugs are effective for treating moderate to severe depression associated with psychomotor and physiological changes such as _____________ and ____________

A

loss of appetite

sleep disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is typically the first benefit of antidepressant therapy?

A

Improvement in sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ideally, patients with moderate to severe depression should be treated with ____________ in addition to drug therapy.

A

psychological therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is dysthymia?

A

lower grade chronic depression; typically of at least 2 years duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dysthymia is a type of ________ (higher/lower) grade chronic depression that is typically of at least __________ duration

A

Lower

2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Antidepressant drugs should not be used routinely in _________ depression

A

mild

*psychological therapy should be considered initially

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When are antidepressants used in the treatment of mild depression?

A

psychological therapy should be considered initially; however, a trial of antidepressant therapy may be considered in cases refractory to psychological treatments or in those associated with psychosocial or medical problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In addition to patients with MILD depression in whom depression is refractory to psychological treatment, which other patients may be considered for antidepressant therapy?

A

Patients with a history of moderate or severe depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the major classes of antidepressants? (4)

A
  1. TCAs
  2. SSRIs
  3. MAOIs
  4. SNRIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Since there may be an interval of ________ before the antidepressant action takes place, electroconvulsive treatment may be required in severe depression when delay is hazardous or intolerable

A

2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Since there may be an interval of 2 weeks before the antidepressant action takes place, ____________ may be required in severe depression when delay is hazardous or intolerable

A

electroconvulsive treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

During the first few weeks of treatment with antidepressants, there is an increased potential for _________, __________, and __________.

A

agitation

anxiety

suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

__________ are better tolerated and are safer in overdose than other classes of antidepressants and should be considered first-line for treating depression.

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In patients with unstable angina or who have had a recent myocardial infarction, ____________ has been shown to be safe in the treatment of depression

A

sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

______________ have similar efficacy to SSRIs but are more likely to be discontinued because of side-effects; toxicity in overdosage is also a problem

A

Tricyclic antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SSRIs are less __________ and have fewer ________ and ________ effects than tricyclic antidepressants.

A

sedating

antimuscarinic

cardiotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

__________ (class of antidepressants) have dangerous interactions with some foods and drugs, and should be reserved for use by specialists

A

MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

___________ or __________ drugs should be used with caution in depression due to the risk of masking the true diagnosis, but they are useful adjuncts in agitated patients

A

Anxiolytics

antipsychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Augmenting antidepressants with __________ under specialist supervision may also be necessary in patients who have depression with psychotic symptoms

A

antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Augmenting antidepressants with antipsychotics under specialist supervision may also be necessary in patients who have depression with ____________ symptoms

A

psychotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Although anxiety is often present in depressive illness (and may be the presenting symptom), the use of an antipsychotic or an anxiolytic may _____________.

A

mask the true diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is St John’s wort?

A

A popular herbal remedy for treating mild depression

Also a CYP450 inducer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

St John’s wort can _________ (induce/inhibit) drug metabolising enzymes and a number of important interactions with conventional drugs, including conventional antidepressants, have been identified.

A

Induce

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

If a patient stops taking St John’s wort, the concentration of interacting drugs may _______ (increase/decrease), leading to toxicity.

A

Increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are the most commonly prescribed SSRIs? (5)

A
  1. Citalopram
  2. Escitalopram
  3. Fluoxetine
  4. Paroxetine
  5. Sertraline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are the most commonly prescribed SNRIs? (2)

A
  1. Venlafaxine

2. Duloxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the most commonly prescribed TCAs? (5)

A
  1. Amitriptyline
  2. Clomipramine
  3. Nortriptyline
  4. Imipramine
  5. Lofepramine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the most commonly prescribed MAOIs? (4)

A
  1. Tranylcypromine
  2. Phenelzine
  3. Isocarboxazid
  4. Moclobemide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Patients should be reviewed every _________ at the start of antidepressant treatment

A

1–2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Treatment should be continued for at least __________ (________ in the elderly) before considering whether to switch antidepressant due to lack of efficacy

A

4 weeks

6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

In patients being treated with antidepressants, how should partial response be managed?

A

In cases of partial response, continue for a further 2–4 weeks (elderly patients may take longer to respond)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Following remission, antidepressant treatment should be continued at the same dose for at least _________ (about __________ in the elderly), or for at least __________ in patients receiving treatment for generalised anxiety disorder (as the likelihood of relapse is high).

A

6 months

12 months

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Patients with a history of recurrent depression should receive maintenance treatment for at least __________.

A

2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Which electrolyte disturbance has been associated with all types of antidepressants?

A

Hyponatremia, usually in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Hyponatremia has been reported more frequently with ________ than with other antidepressants

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

_____________ should be considered in all patients who develop drowsiness, confusion, or convulsions while taking an antidepressant

A

Hyponatraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Hyponatraemia should be considered in all patients who develop ___________, ___________, or __________ while taking an antidepressant

A

drowsiness

confusion

convulsions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

The use of antidepressants has been linked with suicidal thoughts and behaviour; which patient demographics are particularly at risk? (3)

A
  1. Children
  2. Young adults
  3. Patients with a history of suicidal behavior
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Where necessary patients being treated with antidepressants should be monitored for suicidal behaviour, self-harm, or hostility, particularly at the __________ of treatment or if ___________

A

beginning

the dose is changed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is serotonin syndrome?

A

a relatively uncommon adverse drug reaction caused by excessive central and peripheral serotonergic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What are the symptoms of serotonin syndrome? (3)

A

Range from mild to life-threatening

  1. Neuromuscular hyperactivity: tremor, hyperreflexia, clonus, myoclonus, rigidity
  2. Autonomic dysfunction: tachycardia, BP changes, hyperthermia, diaphoresis, shivering, diarrhea
  3. Altered mental state: agitation, confusion, mania
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What factors may precipitate serotonin syndrome in a patient? (5)

A

Can occur within hours or days following:

  1. Initiation of treatment
  2. Dose escalation
  3. Overdose of serotonergic drugs
  4. Addition of a new serotonergic drug
  5. Replacement of one serotonergic drug by another without allowing a long enough washout period in between (particularly when the forest drug is in irreversible MAOI or a drug with a long half-life)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Severe toxicity, which is a medical emergency, usually occurs with a combination of serotonergic drugs, one of which is generally a(n) _________.

A

MAOI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is the treatment of serotonin syndrome?

A
  1. Withdrawal of serotonergic medication

2. Supportive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What are the main classes of serotonergic drugs? (10)

A
  1. SSRIs
  2. SNRIs
  3. Bupropion
  4. TCAs
  5. MAOIs
  6. Anti-migraine medications eg carbamazepine, valproate, triptans
  7. Pain medications eg opioids including over-the-counter cough syrups
  8. Lithium
  9. Antiemetics including 5-HT antagonists and D2 antagonists
  10. St John’s wort
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What is the mechanism of action of bupropion?

A

Norepinephrine and dopamine reuptake inhibitor (SNDRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Failure to respond to initial treatment with an SSRI may require _____________, or ____________.

A

an increase in the dose

switching to a different SSRI or mirtazapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

In which drug class is the antidepressant mirtazapine?

A

Alpha-2 antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

____________ and __________ should be considered for more severe forms of depression

A

tricyclic antidepressants

venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

______________ may be initiated in severe refractory depression

A

Electroconvulsive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Failure to respond to a second antidepressant may require the addition of ____________, or use of an augmenting agent like _________, __________, ____________, __________, or __________ under specialist supervision

A

another antidepressant of a different class

Lithium

Aripiprazole (unlicensed)

Olanzapine (unlicensed)

Quetiapine

Risperidone (unlicensed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Management of acute anxiety generally involves the use of a ____________ or _____________.

A

benzodiazepine

buspirone hydrochloride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

For chronic anxiety (of longer than 4 weeks’ duration) it may be appropriate to use a(n) _____________

A

antidepressant; particularly SSRI or SNRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

For patients with newly diagnosed anxiety, combined therapy with a ____________ may be required until the antidepressant takes effect

A

benzodiazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Patients with generalised anxiety disorder, a form of chronic anxiety, should be offered _____________ before initiating an antidepressant.

A

psychological treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

For patients with chronic anxiety, a(n) ___________ such as ____________, ___________, or __________ [unlicensed], can be used if drug treatment is needed

A

SSRI

escitalopram

paroxetine

sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

In addition to SSRIs escitalopram, paroxetine, and sertraline, _____________ and ____________ (SNRIs) are also recommended for the treatment of generalised anxiety disorder

A

Duloxetine

venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

In patients with chronic anxiety, if SSRIs or SNRIs are not tolerated (or if treatment has failed to control symptoms), ____________ can be considered

A

pregabalin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Panic disorder is treated with _________

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

_______________ or __________ can be used second-line in the treatment of panic disorder. ____________, an SNRI, is also licensed for panic disorder.

A

clomipramine hydrochloride [unlicensed]

imipramine hydrochloride [unlicensed]

Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Obsessive-compulsive disorder, post-traumatic stress disorder, and phobic states such as social anxiety disorder are treated with ______________

A

SSRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What is the first line treatment for OCD?

A

SSRIs

64
Q

What is the first line treatment for PTSD?

A

SSRIs

65
Q

What is the first line treatment for phobic states eg social anxiety disorder?

A

SSRIs

66
Q

_______________ can be used second-line for obsessive-compulsive disorder

A

Clomipramine hydrochloride (TCA)

67
Q

______________ is licensed for the treatment of social anxiety disorder

A

Moclobemide (MAOI)

68
Q

Moclobemide is licensed for the treatment of ______________

A

social anxiety disorder

69
Q

What is the mechanism of action of TCAs?

A

Block re-uptake of both serotonin and noradrenaline

70
Q

Tricyclic and related antidepressant drugs can be roughly divided into those with additional __________ properties and those that are less __________

A

sedative

sedating

71
Q

Agitated and anxious patients tend to respond best to the TCAs with _____________, whereas withdrawn and apathetic patients will often obtain most benefit from the less _________ ones

A

Sedative activity

Sedating

72
Q

TCAs with greater sedative activity are better for depressed patients who also have _________ and __________ symptoms

A

Agitated

Anxious

73
Q

TCAs with less sedative activity are better for depressed patients who also have _________ and __________ symptoms

A

Withdrawn

Apathetic

74
Q

Which TCAs have sedative properties? (7)

A
  1. Amitriptyline
  2. Clomipramine
  3. Dosulepin
  4. Doxepin
  5. Mianserin
  6. Trazodone
  7. Trimipramine
75
Q

Which TCAs have less sedating properties? (3)

A
  1. Imipramine
  2. Lofepramine
  3. Nortriptyline
76
Q

____________ (TCA) has a lower incidence of side-effects and is less dangerous in overdosage but is infrequently associated with hepatic toxicity

A

Lofepramine

77
Q

Imipramine hydrochloride has more marked _________________ side-effects than other tricyclic and related antidepressants

A

antimuscarinic

78
Q

______________ and ______________ are effective but they are particularly dangerous in overdosage and are not recommended for the treatment of depression

A

Amitriptyline

dosulepin

79
Q

Amitriptyline hydrochloride and dosulepin hydrochloride are effective but they are particularly dangerous in overdosage and are not recommended for the treatment of _____________

A

depression

80
Q

Low doses of TCAs should be used for initial treatment in _____________ (patient population).

A

the elderly

81
Q

In most patients the long half-life of tricyclic antidepressant drugs allows once-daily administration, usually ______________

A

at night

82
Q

Studies have shown that tricyclic antidepressants are not effective for treating depression in ___________ (patient population).

A

children

83
Q

The use of tricyclic antidepressants in elderly patients is potentially inappropriate (STOPP criteria):
If prescribed in those with… (5)

A
  1. Dementia
  2. Narrow angle glaucoma
  3. Cardiac conduction abnormalities
  4. Prostatism
  5. History of urinary retention
84
Q

Can TCAs be used as first line antidepressant treatment in the elderly?

A

No; more appropriate to prescribe SSRIs or SNRIs which have a lower risk of adverse drug reactions

85
Q

It is easier to prescribe __________ (MAOIs/TCAs) when ___________ (MAOIs/TCAs) have been unsuccessful than vice versa.

A

MAOIs

TCAs

86
Q

_______________ has a greater stimulant action than phenelzine or isocarboxazid and is more likely to cause a hypertensive crisis

A

Tranylcypromine

all MAOIs

87
Q

Tranylcypromine has a greater stimulant action than phenelzine or isocarboxazid and is more likely to cause a _____________

A

hypertensive crisis

88
Q

_____________ and ___________ are more likely to cause hepatotoxicity than tranylcypromine.

A

Isocarboxazid

phenelzine

(All MAOIs)

89
Q

Isocarboxazid and phenelzine are more likely to cause ____________ than tranylcypromine.

A

hepatotoxicity

90
Q

______________ (MAOI) should be reserved as a second line treatment

A

Moclobemide

91
Q

Phobic patients and depressed patients with atypical, hypochondriacal, or hysterical features are said to respond best to ___________ (class of antidepressants)

A

MAOIs

92
Q

____________ patients and depressed patients with ____________, ____________, or ___________ features are said to respond best to MAOIs

A

Phobic

atypical

hypochondriacal

hysterical

93
Q

__________ should be tried in any patients who are refractory to treatment with other antidepressants as there is occasionally a dramatic response

A

MAOIs

94
Q

Response to treatment with MAOIs may be delayed for __________ or more and may take an additional 1 or 2 weeks to become maximal.

A

3 weeks

95
Q

Response to treatment with MAOIs may be delayed for 3 weeks or more and may take an additional ___________ to become maximal.

A

1 or 2 weeks

96
Q

Other antidepressants should not be started for ___________ after treatment with MAOIs has been stopped (___________ if starting clomipramine or imipramine)

A

2 weeks

3 weeks

97
Q

An MAOI should not be started until at least ___________ after a previous MAOI has been stopped (then started at a reduced dose)

A

2 weeks

98
Q

An MAOI should not be started until at least ___________ after a TCA (___________ in the case of clomipramine or imipramine) has been stopped

A

7-14 days

3 weeks

99
Q

An MAOI should not be started until at least ___________ after an SSRI (at least ___________ in the case of fluoxetine) has been stopped

A

1 week

5 weeks

100
Q

An MAOI should not be started until at least 2 weeks after a ___________ has been stopped (then started at a reduced dose)

A

previous MAOI

101
Q

An MAOI should not be started until at least 7–14 days after a __________ (3 weeks in the case of _____________ or __________) has been stopped

A

TCA

clomipramine

imipramine

102
Q

An MAOI should not be started until at least a week after a(n) ____________ (at least 5 weeks in the case of ____________) has been stopped

A

Fluoxetine

103
Q

_____________, an antidepressant thought to directly modulate serotonergic receptor activity and inhibit the re-uptake of serotonin, is recommended in patients whose condition has responded inadequately to 2 antidepressants within the current episode

A

Vortioxetine

104
Q

_____________ is licensed for use in treatment-resistant depression, used as monotherapy and as an adjunct to other antidepressant drugs

A

Tryptophan

Should be initiated by hospital specialists

105
Q

SSRIs and SNRIs are correlated with a small increased risk of __________ when used in the month before delivery

A

Postpartum hemorrhage

*SSRIs are known to increase the risk of bleeding due to their effect on platelet function; this may be significant in patients with other risk factors for bleeding disorders

** Anticoagulant medication in women at high risk of thrombotic events should not be stopped, however, prescribers should be aware of the risk identified.

106
Q

What are the contraindications to use of SSRIs? (2)

A
  1. Poorly controlled epilepsy

2. Mania

107
Q

SSRIs should be prescribed with caution in which patients? (7)

A
  1. Cardiac disease
  2. Concurrent ECT
  3. DM
  4. Epilepsy (discontinue if convulsions develop)
  5. History of bleeding disorders, esp. GI bleeding
  6. History of mania
  7. Susceptibility to angle-closure glaucoma
108
Q

What are the side effects associated with SSRIs? (5)

A
  1. Neuro/Psych: anxiety, impaired concentration, confusion, depersonalization, drowsiness, headache, mydriasis, paresthesias, visual impairment, sleep disorders, tinnitus
  2. GI: change in appetite and taste, constipation, diarrhea, discomfort, nausea, vomiting, weight changes, hemorrhage, dry mouth
  3. MSK: arthralgia, myalgia, tremor, skin reactions, hyperhydrosis
  4. Other: arrhythmias/QT interval prolongation, fever, urinary disorders, sexual dysfunction
109
Q

Sexual dysfunction is most commonly associated with which class of antidepressant?

A

SSRIs

May persist after treatment has stopped

110
Q

Symptoms of poisoning by ____________ include nausea, vomiting, agitation, tremor, nystagmus, drowsiness, and sinus tachycardia; convulsions may occur.

A

selective serotonin re-uptake inhibitors

111
Q

Rarely, severe poisoning with ________ results in ___________, with marked neuropsychiatric effects, neuromuscular hyperactivity, and autonomic instability; hyperthermia, rhabdomyolysis, renal failure, and coagulopathies may develop.

A

SSRIs

serotonin syndrome

112
Q

Which common or very common side effects are specifically associated with the SSRI, sertraline? (6)

A
  1. Chest pain
  2. Depression
  3. GI disorders
  4. Increased risk of infection
  5. NM dysfunction
  6. Vasodilation
113
Q

What serious side effects have been associated with sertraline? (4)

A
  1. Cerebrovascular insufficiency
  2. Leukopenia
  3. NMS
  4. Pancreatitis
114
Q

Are SSRIs safe to use in pregnancy and breastfeeding?

A

Avoid in pregnancy unless benefit outweighs risk

Not known to be harmful but consider is continuing breastfeeding

115
Q

If SSRIs are used during the third trimester there is a risk of _____________, and _____________ has been reported.

A

neonatal withdrawal symptoms

persistent pulmonary hypertension in the newborn

116
Q

Does dosing of SSRIs in hepatic and/or renal dysfunction need to be adjusted?

A

Prolonged half-life in hepatic impairment; caution

Avoid sertraline in severe impairment and reduce dose in mild to moderate disease

117
Q

What are the symptoms of abrupt withdrawal of SSRIs? (13)

A
  1. GI disturbance
  2. Headache
  3. Anxiety
  4. Dizziness
  5. Paresthesias
  6. Electric shock sensation in the head, neck, and spine
  7. Tinnitus
  8. Sleep disturbances
  9. Fatigue
  10. Flu-like symptoms
  11. Sweating
  12. Visual disturbances
  13. Palpitations
118
Q

The dose of SSRIs should be tapered over at least _____________ to avoid the effects of rapid withdrawal

A

a few weeks

*longer if sertraline

119
Q

Withdrawal effects may occur within __________ of stopping treatment with SSRIs; they are usually mild and self-limiting, but in some cases may be severe

A

5 days

120
Q

Sertraline should preferably be reduced gradually over about ___________, or longer if withdrawal symptoms emerge (_________ in patients who have been on long-term maintenance treatment).

A

4 weeks

6 months

121
Q

Patients and carers should be advised that patients taking SSRIs may have impaired ability to ___________

A

Drive and perform skilled tasks eg operating machinery

122
Q

____________, __________ and _______________ increase the risk of bleeding when used in combination with SSRIs

A

NSAIDs

Anticoagulants

Antiplatelets

123
Q

Escitalopram is the active enantiomer of __________.

A

citalopram (both SSRIs)

124
Q

What is the main contraindication specific to escitalopram?

A

QT-prolongation

125
Q

What is a common side effects associated with paroxetine (SSRI)?

A

Blurred vision

126
Q

Paroxetine is associated with a __________ (higher/lower) risk of withdrawal reactions compared to other SSRIs

A

Higher

127
Q

Which antidepressants are LEAST likely to cause sexual side effects? (4)

A
  1. Bupropion
  2. Mirtazapine
  3. Vortioxetine
  4. Vilazodone
128
Q

Which antidepressants are MOST likely to cause sexual side effects? (4)

A
  1. SSRIs
  2. SNRIs
  3. TCAs
  4. MAOIs
129
Q

What are the contraindications to the use of TCAs? (5)

A
  1. Acute porphyrias
  2. Arrhythmias
  3. Mania
  4. Heart block
  5. Immediate recovery period after MI
130
Q

TCAs should be prescribed with caution in which patients? (13)

A
  1. CVD
  2. Chronic constipation
  3. Epilepsy
  4. History of bipolar disorder
  5. History of psychosis
  6. Hyperthyroidism (risk of arrhythmia)
  7. Increased IOP
  8. Significant suicide risk
  9. Phaeochromocytoma (risk of arrhythmias)
  10. Prostatic hypertrophy
  11. Risk of QT prolongation (correct hypokalemia before initiating treatment)
  12. Susceptibility to angle closure glaucoma
  13. Urinary retention
131
Q

For patients taking TCAs, treatment should be stopped or dose reduced if the patient enters a _____________

A

Manic phase

132
Q

____________ patients are particularly susceptible to many of the side-effects of tricyclic antidepressants

A

Elderly

*low initial doses should be used, with close monitoring, particularly for psychiatric and cardiac side-effects

133
Q

What are the common or very common side effects of TCAs? (5)

A
  1. Neuropsychiatric: aggression, anxiety, impaired concentration, confusion, delirium, depersonalization, exacerbation of depression, drowsiness, fatigue, hallucinations, headache, hot flushes, hyperhydrosis, memory loss, altered mood, movement disorders, mydriasis, sexual dysfunction, sleep disorders, altered taste, tinnitus, vision disorders, speech disorder
  2. CV: arrhythmias, hypotension, palpitations
  3. GI/GU: constipation, diarrhea, dry mouth, nausea, urinary disorders
  4. Endocrine: breast enlargement, galactorrhea, weight increased
  5. MSK: muscle tone increased, muscle weakness, skin reactions
134
Q

What are the dangerous side effects associated with TCAs? (6)

A
  1. Agranulocytosis
  2. NMS
  3. Vaginal hemorrhage
  4. Rhabdomyolysis
  5. Serotonin syndrome
  6. Suicidal behaviors
135
Q

Patient taking TCAs should be encouraged to ____________ treatment if side-effects develop

A

Continue

*some tolerance to side-effects seems to develop; the risk of side-effects is reduced by titrating slowly to the minimum effective dose (every 2–3 days)

136
Q

Overdose of _____________ cause dry mouth, coma of varying degree, hypotension, hypothermia, hyperreflexia, extensor plantar responses, convulsions, respiratory failure, cardiac conduction defects, and arrhythmias. Dilated pupils and urinary retention also occur

A

TCAs

Antimuscarinic effects among other symptoms of autonomic dysregulation

137
Q

____________ have been reported when TCAs are used during the third trimester of pregnancy

A

Neonatal withdrawal symptoms

138
Q

Are TCAs safe to use in breastfeeding?

A

Yes

139
Q

Can TCAs be used in hepatic impairment?

A

Use caution; avoid in severe impairment due to risk of hypertensive crisis

140
Q

Is monitoring required with TCA use?

A

Monitoring of cardiac and hepatic function during long-term use

141
Q

Manufacturer advises monitoring of __________ and ___________ function during long-term use of TCAs

A

Cardiac

Hepatic

142
Q

The risk of withdrawal symptoms is increased if the antidepressant is stopped suddenly after regular administration for __________ or more.

A

8 weeks

143
Q

Limited quantities of ___________ should be prescribed at any one time because their cardiovascular and epileptogenic effects are dangerous in overdosage.

A

TCAs

144
Q

Limited quantities of tricyclic antidepressants should be prescribed at any one time because their ___________ and _________ effects are dangerous in overdosage.

A

cardiovascular

epileptogenic

145
Q

Effects of alcohol are enhanced when patients are taking _____________ (class of antidepressant)

A

TCAs

146
Q

Overdosage with _____________ (antidepressant) is associated with a relatively high rate of fatality.

A

Amitriptyline

*Symptoms of overdosage may include dry mouth, coma of varying degree, hypotension, hypothermia, hyperreflexia, extensor plantar responses, convulsions, respiratory failure, cardiac conduction defects, and arrhythmias; Dilated pupils and urinary retention also occur

147
Q

What are the symptoms of NMS? (6)

A
  1. Muscle rigidity (diffuse “lead pipe”)
  2. Fever
  3. Tachycardia
  4. Diaphoresis
  5. Hyporeflexia
  6. Hypertension

*gradual onset

(VS serotonin syndrome which is characterized by hyperreflexia, myoclonus, nausea, diarrhea)

148
Q

What is the mechanism of action of MAOIs?

A

MAOIs inhibit monoamine oxidase, thereby causing an accumulation of amine neurotransmitters.

149
Q

What are the contraindications to MAOIs? (4)

A
  1. Cerebrovascular disease
  2. Mania
  3. Phaeochromocytoma
  4. Severe CVD
150
Q

What are the side effects associated with MAOIs?

A

Akathisia; anxiety; appetite increased; arrhythmia; asthenia; behaviour abnormal; blood disorder; confusion; constipation; dizziness; drowsiness; dry mouth; dysuria; hallucination; headache; hyperhidrosis; insomnia; jaundice; nausea; paraesthesia; peripheral neuritis; postural hypotension (more common in elderly); reflexes increased; skin reactions; suicidal behaviours; tremor; vision blurred; vomiting; weight increased

151
Q

Discontinue MAOIs if __________ or __________ occur

A

Palpitations

Frequent headaches

152
Q

Are MAOIs safe in pregnancy?

A

Increased risk of neonatal malformations; avoid unless compelling reasons

153
Q

Are MAOIs safe to use in hepatic and/or renal impairment?

A

Avoid in hepatic impairment

154
Q

What monitoring is advised for patients taking MAOIs?

A

Monitor BP due to risk of hypotension and hypertensive responses

155
Q

What are the symptoms of abrupt MAOI withdrawal? (10)

A
  1. agitation
  2. irritability
  3. ataxia
  4. movement disorders
  5. insomnia
  6. drowsiness
  7. vivid dreams
  8. cognitive impairment
  9. slowed speech
  10. Hallucinations and paranoid delusions
156
Q

What additional information should be given to patients and carers regarding MAOIs?

A
  1. Patients should be advised to eat only fresh foods and avoid food that is suspected of being stale or ‘going off’. This is especially important with meat, fish, poultry or offal; game should be avoided. The danger of interaction persists for up to 2 weeks after treatment with MAOIs is discontinued.
  2. Patients should also be advised to avoid alcoholic drinks or de-alcoholised (low alcohol) drinks.
  3. Drowsiness may affect performance of skilled tasks (e.g. driving).